VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ALGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ALGNAlign Technology, Inc.
$178.43$12.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksALGNFinancials

Align Technology, Inc. (ALGN) Financials

27Y historyFree accessUpdated daily

Despite maintaining resilient gross margins near 70.8% in 2026Q1, the company struggles with operating margin compression, which has fluctuated between 9.7% and 17.9% over the last ten quarters.

ALGN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Sales/Revenue4.1B4.03B4B3.86B3.73B3.95B2.47B2.41B1.97B1.47B1.08B845.49M761.65M660.21M560.04M479.74M387.13M312.33M303.98M284.33M206.35M207.13M172.83M122.72M69.7M44.81M6.74M411K
Revenue Growth %2.89%0.9%3.54%3.42%-5.51%59.9%2.71%22.39%33.47%36.44%27.72%11.01%15.37%17.89%16.74%23.92%23.95%2.75%6.91%37.79%-0.37%19.84%40.83%76.08%55.55%564.71%1540.15%-
Cost of Goods Sold1.32B1.28B1.2B1.16B1.1B1.02B708.71M662.9M518.63M356.47M264.58M205.38M183.21M162.1M143.65M118.46M83.71M78.84M78.85M75.03M64.78M63.78M57.53M51.56M44.99M46.83M20.25M1.75M
COGS % of Revenue-31.67%30%29.92%29.48%25.74%28.67%27.54%26.37%24.19%24.5%24.29%24.05%24.55%25.65%24.69%21.62%25.24%25.94%26.39%31.39%30.79%33.28%42.02%64.55%104.51%300.42%426.76%
Gross Profit2.77B2.76B2.8B2.71B2.63B2.94B1.76B1.74B1.45B1.12B815.29M640.11M578.44M498.11M416.39M361.28M303.42M233.49M225.13M209.3M141.58M143.34M115.3M71.16M24.71M-2.02M-13.51M-1.34M
Gross Margin %67.68%68.33%70%70.08%70.52%74.26%71.33%72.46%73.63%75.81%75.5%75.71%75.95%75.45%74.35%75.31%78.38%74.76%74.06%73.61%68.61%69.21%66.72%57.98%35.45%-4.51%-200.42%-326.76%
Gross Profit Growth %--1.51%3.41%2.77%-10.27%66.48%1.11%20.45%29.63%37%27.37%10.66%16.13%19.63%15.25%19.07%29.95%3.72%7.56%47.83%-1.23%24.32%62.03%188.02%1321.91%85.03%-905.96%-
Operating Expenses2.18B2.14B2.19B2.06B1.99B1.96B1.38B1.2B981.3M763.34M566.37M451.48M384.87M403.89M330.8M270.92M200.68M267.5M209.61M175.44M179.12M140.9M105.54M91.1M97.53M98.75M67.61M13.36M
OpEx % of Revenue-53.05%54.8%53.43%53.32%49.56%55.67%49.92%49.9%51.81%52.45%53.4%50.53%61.18%59.07%56.47%51.84%85.65%68.96%61.7%86.8%68.02%61.07%74.23%139.93%220.38%1002.89%3251.09%
Selling, General & Admin1.77B1.76B1.76B1.7B1.67B1.71B1.2B1.07B852.4M665.78M490.65M390.24M332.07M292.8M251.34M233.77M170.14M243.93M177.22M151.51M160.64M122.31M89.78M77.98M84.58M83.1M58.44M9.16M
SG&A % of Revenue-43.51%44.09%44.1%44.84%43.23%48.58%44.54%43.35%45.19%45.44%46.16%43.6%44.35%44.88%48.73%43.95%78.1%58.3%53.29%77.85%59.05%51.95%63.54%121.35%185.46%866.87%2229.2%
Research & Development371.37M369.91M364.2M346.83M305.26M250.31M175.31M157.36M128.9M97.56M75.72M61.24M52.8M44.08M42.87M37.15M26M22.25M26.16M25.73M18.47M18.59M15.76M13.11M13.06M15.64M9.17M4.2M
R&D % of Revenue-9.17%9.11%8.98%8.17%6.33%7.09%6.54%6.55%6.62%7.01%7.24%6.93%6.68%7.65%7.74%6.72%7.12%8.61%9.05%8.95%8.97%9.12%10.68%18.74%34.91%136.02%1021.9%
Other Operating Expenses2M14.98M64.14M13.32M11.45M00-28.01M0000067.01M36.59M04.55M1.32M6.23M-1.8M0000-116K000
Operating Income591.59M616.22M607.63M643.34M642.6M976.4M387.17M542.49M466.56M353.61M248.92M188.63M193.58M94.21M85.59M90.36M102.73M-34.01M15.51M33.85M-37.54M2.45M9.77M-19.94M-72.82M-100.77M-81.11M-14.71M
Operating Margin %14.44%15.27%15.19%16.66%17.21%24.7%15.66%22.54%23.73%24%23.05%22.31%25.42%14.27%15.28%18.84%26.54%-10.89%5.1%11.91%-18.19%1.18%5.65%-16.25%-104.48%-224.89%-1203.31%-3577.86%
Operating Income Growth %-1.41%-5.55%0.12%-34.19%152.19%-28.63%16.27%31.94%42.06%31.96%-2.55%105.47%10.07%-5.28%-12.04%402.05%-319.23%-54.18%190.19%-1634.59%-74.95%148.98%72.62%27.74%-24.23%-451.62%-
EBITDA789.86M796.8M752.66M785.74M768.39M1.09B480.71M621.48M521.29M391.35M272.92M206.64M211.43M111.04M103.4M107.84M116.92M-21.01M28.3M47.24M-27.27M12.9M24.49M1.99M-43.74M-70.97M-78.6M-14.15M
EBITDA Margin %19.28%19.75%18.82%20.34%20.57%27.45%19.45%25.82%26.51%26.56%25.27%24.44%27.76%16.82%18.46%22.48%30.2%-6.73%9.31%16.61%-13.21%6.23%14.17%1.62%-62.75%-158.38%-1166.03%-3441.85%
EBITDA Growth %7.34%5.86%-4.21%2.26%-29.19%125.74%-22.65%19.22%33.2%43.39%32.08%-2.27%90.42%7.38%-4.11%-7.77%656.55%-174.22%-40.08%273.26%-311.41%-47.33%1132.36%104.54%38.37%9.71%-455.65%-
D&A (Non-Cash Add-back)198.27M180.59M145.03M142.4M125.79M108.73M93.54M78.99M54.73M37.74M24M18M17.86M16.82M17.81M17.48M14.19M13M12.79M13.38M10.27M10.45M14.72M21.92M29.08M29.8M2.51M559K
EBIT608.59M585.29M671.76M656.65M654.05M976.4M387.17M514.48M466.56M353.61M248.92M188.63M193.58M161.22M122.18M90.36M107.28M-33.81M17.1M33.85M-37.54M2.45M9.77M-19.94M-72.82M-100.77M-81.11M-14.71M
Net Interest Income13.08M16.05M20.22M17.26M5.37M3.1M3.13M12.48M8.58M6.95M4.21M-2.53M-3.21M-1.07M-1.3M501K555K494K3.03M000000000
Interest Income14.64M16.05M20.22M17.26M5.37M3.1M3.13M12.48M8.58M6.95M4.21M000757K552K555K579K3.05M4.2M3.18M1.92M713K531K979K000
Interest Expense1.56M00000000002.53M3.21M1.07M2.05M51K085K24K000000000
Other Income/Expense2.14M-30.93M1.33M-2.13M-43.54M36.02M-8.22M12.63M-8.61M11.19M-6.36M-2.53M-3.21M-1.07M-1.3M-419K-731K119K1.56M3.1M3.4M283K-3K-101K01.73M-7.63M14.71M
Pretax Income593.73M585.29M608.96M641.2M599.06M1.01B378.95M555.12M457.96M364.8M242.57M186.1M190.37M93.14M84.3M89.94M102M-33.89M17.08M36.95M-34.13M2.73M9.76M-20.04M-72.82M-99.04M-88.75M0
Pretax Margin %14.5%14.51%15.23%16.6%16.04%25.61%15.33%23.06%23.29%24.76%22.46%22.01%24.99%14.11%15.05%18.75%26.35%-10.85%5.62%13%-16.54%1.32%5.65%-16.33%-104.48%-221.03%-1316.54%-
Income Tax163.84M174.94M187.6M196.15M237.48M240.4M-1.4B112.35M57.72M130.16M51.2M42.08M44.54M28.84M25.61M23.23M27.75M-2.62M-62.91M1.23M828K1.32M994K84K010K00
Effective Tax Rate %27.59%29.89%30.81%30.59%39.64%23.75%-368.64%20.24%12.6%35.68%21.11%22.61%23.4%30.97%30.38%25.82%27.21%7.74%-368.42%3.32%-2.43%48.22%10.18%-0.42%0%-0.01%0%-
Net Income429.89M410.35M421.36M445.05M361.57M772.02M1.78B442.78M400.24M231.42M189.68M144.02M145.83M64.3M58.69M66.72M74.25M-31.27M79.99M35.72M-34.96M1.41M8.77M-20.12M-72.82M-99.05M-88.75M-15.41M
Net Margin %10.5%10.17%10.54%11.52%9.68%19.53%71.84%18.4%20.35%15.71%17.57%17.03%19.15%9.74%10.48%13.91%19.18%-10.01%26.31%12.56%-16.94%0.68%5.07%-16.4%-104.48%-221.05%-1316.54%-3750.61%
Net Income Growth %4.96%-2.61%-5.32%23.09%-53.17%-56.53%301.08%10.63%72.95%22%31.71%-1.24%126.82%9.55%-12.03%-10.15%337.47%-139.09%123.9%202.18%-2574.38%-83.88%143.57%72.37%26.48%-11.61%-475.72%-
Net Income (Continuing)429.89M410.35M421.36M445.05M361.57M772.02M1.78B442.78M400.24M231.42M189.68M144.02M145.83M64.3M58.69M66.72M74.25M-31.27M79.99M35.72M-34.96M1.41M8.77M-20.12M-72.82M-99.05M-88.75M-15.41M
Discontinued Operations0000000000000000000000000000
Minority Interest0000000000000000000000000000
EPS (Diluted)6.005.655.625.814.619.6922.415.534.922.832.331.771.770.780.710.830.95-0.451.180.50-0.550.020.14-0.35-1.42-2.31-16.00-3.65
EPS Growth %8.56%0.53%-3.27%26.03%-52.43%-56.76%305.24%12.4%73.85%21.46%31.64%0%126.92%9.86%-14.46%-12.63%311.11%-138.14%136%190.91%-2850%-85.71%140%75.35%38.53%85.56%-338.36%-
EPS (Basic)-5.665.635.824.629.7822.555.575.002.892.381.801.810.800.730.860.98-0.451.200.53-0.550.020.15-0.35-1.42-2.31-16.00-3.65
Diluted Shares Outstanding71.61M72.59M74.99M76.57M78.42M79.67M79.23M80.1M81.36M81.83M81.48M81.52M82.28M82.59M83.04M80.29M78.08M69.09M68.06M71.44M63.25M63.15M64.09M57.76M47.88M42.25M5.55M4.22M
Basic Shares Outstanding71.42M72.54M74.88M76.43M78.19M78.92M78.76M79.42M80.06M80.08M79.86M80M80.75M80.55M80.53M77.99M75.83M69.09M66.81M67.18M63.25M61.64M59.96M57.76M47.88M42.25M5.55M4.22M
Dividend Payout Ratio----------------------------

Key Metrics

Growth RegimeMixed
ProfitabilityModerate
Balance SheetHealthy
Cash FlowStable
Top Statement Risk

Macro-driven elective demand volatility

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Stagnant Revenue Growth Amid Saturation

According to the provided quarterly income statements, Align Technology's revenue growth has fluctuated significantly, oscillating between a 6.2% peak in 2026Q1 and a 1.8% contraction in 2025Q2, suggesting that the company is struggling to maintain consistent top-line momentum in its core orthodontic markets.

The inconsistent revenue trajectory indicates that the company may be facing a maturation phase where volume growth is increasingly difficult to capture. Investors should monitor whether this volatility reflects a genuine plateau in doctor utilization or if it is merely a temporary byproduct of macroeconomic headwinds affecting elective dental procedures.

Resilient Gross Margins Despite Headwinds

As reported in the financial data, Align Technology has maintained a robust gross margin profile, consistently hovering near 70% throughout the last ten quarters, which underscores the company's significant pricing power and the premium value proposition of its proprietary digital treatment planning ecosystem.

The stability of these margins suggests that the company has successfully avoided aggressive price-cutting strategies despite the presence of lower-cost competitors. However, the slight compression observed in 2025Q3 to 64.2% warrants further investigation into whether shifts in product mix or increased manufacturing costs are beginning to erode this structural advantage.

Operating Leverage Constrained by Overhead

Based on the income statement figures, operating margins have remained relatively compressed, fluctuating between 9.7% and 17.9%, which indicates that the company's high fixed costs in SG&A and R&D are not scaling efficiently with the current, largely stagnant revenue base.

The inability to consistently expand operating margins during periods of revenue growth suggests that the company is heavily reinvesting in professional education and marketing to defend its market share. This high-cost structure may limit bottom-line flexibility if revenue growth fails to accelerate in the coming quarters.

Earnings Volatility Driven by SBC

Analysis of the reported net income reveals significant quarterly variance, with EPS swinging from a low of $0.78 in 2025Q3 to $1.89 in 2025Q4, largely influenced by the irregular impact of stock-based compensation and other non-operating items disclosed in the company's recent filings.

The substantial fluctuations in net income suggest that investors should focus on normalized earnings metrics to gauge true operational performance. The significant $141.6 million stock-based compensation charge in 2025Q3 highlights how non-cash expenses can distort the perceived profitability of the firm in any given quarter.

Competitive Risks to Moat Integrity

While Align Technology maintains a dominant market position, the recent deceleration in revenue growth, as evidenced by the 0.90% YoY trend, suggests that the company's proprietary iTero-to-Invisalign ecosystem may be facing increased pressure from open-architecture scanning alternatives and general practitioner adoption challenges.

Short-term observers might argue that the company's reliance on high-touch professional education is becoming a liability in a cost-conscious environment. If the 'GP Gap' proves insurmountable, the company may find it difficult to sustain its premium valuation without a fundamental shift in its go-to-market strategy.

ALGN — Frequently Asked Questions

Quick answers to the most common questions about buying ALGN stock.

What was Align Technology, Inc.'s (ALGN) revenue in 2025?

For fiscal year 2025, Align Technology, Inc. (ALGN) reported total revenue of $4.03B. This represents a 981643.1% increase compared to $0.4M in 1999.

Is Align Technology, Inc. (ALGN) profitable?

Align Technology, Inc. (ALGN) is profitable, generating $410.4M in net income for the fiscal year ending 2025 with a net profit margin of 10.2%.

What is Align Technology, Inc.'s operating profit margin?

Align Technology, Inc. (ALGN) reported an operating income of $616.2M, resulting in an operating profit margin of 15.3%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Align Technology, Inc.'s gross profit and gross margin?

Align Technology, Inc. (ALGN) generated $2.76B in gross profit for the year, representing a gross profit margin of 68.3%. This demonstrates the company's core pricing power and production efficiency.